Skip to content

Orphan Drugs And Rare Diseases: Review #3 Of 2013

July 17, 2013

This is the third in a series of Blog Posts on the review of the first six months of 2013 in the orphan drug and rare disease space.

This Blog Post will compare the number of EMA COMP’s (European Medicines Agency’s Committee for Orphan Medicinal Products) positive opinions recommending Orphan Drug Designation (ODD) from the first 6 months of 2013 versus the number of EMA COMP ODDs from the first 6 months of 2012.

Month

# of 2012 EMA COMP ODDs

# of 2013 EMA COMP ODDs

% Change   From 2012 To   2013

January

16

8

   50.0   % –

February

7

12

 71.4 %

March

13

7

      46.1 % –

April

8

11

 37.5 %

May

16

10

      37.5 % –

June

9

22

144.4 %

Grand Totals

69

70

     1.4 %

# of 2012 EMA COMP ODDs” Column Link = Is the EMA COMP 2012 Meeting Report

# of 2013 EMA COMP ODDs” Column Link = Is the Orphan Druganaut Blog Post that contains the detail chart listing for each month in 2013.

Please Note: “A group of three balloons on ribbons” JPEG by AJ (Open clip Art Library image’s page) [see page for license] | Wikimedia Commons.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: